These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19783392)

  • 1. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules.
    Maruyama H; Takahashi M; Sekimoto T; Kamesaki H; Shimada T; Kanai F; Yokosuka O
    Ultrasound Med Biol; 2012 Mar; 38(3):383-8. PubMed ID: 22261511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
    Mandai M; Koda M; Matono T; Nagahara T; Sugihara T; Ueki M; Ohyama K; Murawaki Y
    Br J Radiol; 2011 Jun; 84(1002):499-507. PubMed ID: 20959373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.
    Koda M; Matsunaga Y; Ueki M; Maeda Y; Mimura K; Okamoto K; Hosho K; Murawaki Y
    Eur Radiol; 2004 Jun; 14(6):1100-8. PubMed ID: 14676975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent.
    Yoshizumi H; Maruyama H; Okugawa H; Kobayashi S; Akiike T; Yoshikawa M; Ebara M; Yokosuka O; Matsutani S; Kondo F; Kamiyama N
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1528-34. PubMed ID: 17944882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
    Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
    Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.